Identification of candida species isolated from clinical samples and investigating antifungal susceptibility in Turkey

Basit Öğe Kaydı
dc.contributor.authorAydin E.
dc.contributor.authorKarakas A.
dc.contributor.authorSavasci U.
dc.contributor.authorAkpak Y.K.
dc.contributor.authorCaymaz S.O.
dc.contributor.authorAydin S.
dc.contributor.authorAvci M.
dc.contributor.authorGul H.C.
dc.contributor.authorCoskun O.
dc.contributor.authorCoskuner S.A.
dc.contributor.authorMetin D.Y.
dc.contributor.authorOzgenc O.
dc.contributor.authorEyigun C.P.
dc.date.accessioned2019-10-26T21:32:55Z
dc.date.available2019-10-26T21:32:55Z
dc.date.issued2014
dc.departmentEge Üniversitesien_US
dc.description.abstractObjectives: The purpose of this study is identify typology of candida species from patients' samples, and determine their invitro antifungal susceptibility. Materials and methods: In this study, Candida species isolated from patients who applied to our laboratory between 2009-2010 were included in order to identify the types of Candida and to carry out their antifungal sensitivity. The Candida species were typed using germ tube test, corn meal Tween-80 and BBL CHROMagar medium, and API ID32C yeast identification system. Antifungal drugs' susceptibility of Candida species for amphotericin B, fluconazole, itraconazole, and voriconazole were conducted through microdilution system. Results: Of the 97 Candida species, 58.76% were identified as Candida albicans, other identified types were as follows: C. parapsilosis (13.4%), C. glabrata (11.3%), C. tropicalis (5.15%) respectively. Antifungal drugs sensitivity tests results revealed 1.03% resistance to fluconazole and 4.12% to itracanazole, whereas no resistance was found to amphotericin B and voriconazole. Conclusion: Target population for Candida has gradually been expanding. Therefore, it may be suggested that determining the type of pathogen and running its susceptibility tests are significant factors that will enhance the success of the treatment before empirical treatment against Candida infections is initiated.en_US
dc.identifier.endpage568en_US
dc.identifier.issn0393-6384
dc.identifier.issn0393-6384en_US
dc.identifier.issue3en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage561en_US
dc.identifier.urihttps://hdl.handle.net/11454/17788
dc.identifier.volume30en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherActa Medica Mediterraneaen_US
dc.relation.ispartofActa Medica Mediterraneaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleIdentification of candida species isolated from clinical samples and investigating antifungal susceptibility in Turkeyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu